Prognostic significance of MicroRNA-375 downregulation in solid tumors: A meta-analysis

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Shao, Yingjie ^a   Geng, Yiting ^a   Gu, Wendong ^a   Huang, Jin ^a   Ning, Zhonghua ^a   Pei, Honglei ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 375; MICRORNA; MIRN375 MICRORNA, HUMAN; TUMOR MARKER;

BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL EVALUATION; COCHRANE LIBRARY; COLORECTAL CANCER; CONFIDENCE INTERVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; GLIOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SOLID TUMOR; STOMACH CANCER; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; DOWN REGULATION; ESOPHAGEAL NEOPLASMS; GENETICS; META ANALYSIS; METABOLISM; PROGNOSIS;

CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; HUMANS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84910608695     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/626185     Document Type: Review

References (61)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. A Cancer Journal for Clinicians 2011 61 2 69 90 10.3322/caac.20107 2-s2.0-79952232216
2. Kim V. N., Han J., Siomi M. C., Biogenesis of small RNAs in animals. Nature Reviews Molecular Cell Biology 2009 10 2 126 139 10.1038/nrm2632 2-s2.0-58849112575
3. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N., Widespread changes in protein synthesis induced by microRNAs. Nature 2008 455 7209 58 63 10.1038/nature07228 2-s2.0-49949117302
4. Friedman R. C., Farh K. K. H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 10.1101/gr.082701.108 2-s2.0-60149095444
5. Garzon R., Fabbri M., Cimmino A., Calin G. A., Croce C. M., MicroRNA expression and function in cancer. Trends in Molecular Medicine 2006 12 12 580 587 10.1016/j.molmed.2006.10.006 2-s2.0-33751163757
6. Di Leva G., Croce C. M., MiRNA profiling of cancer. Current Opinion in Genetics and Development 2013 23 1 3 11 10.1016/j.gde.2013.01.004 2-s2.0-84877921098
7. Poy M. N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., MacDonald P. E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004 432 7014 226 230 10.1038/nature03076 2-s2.0-9144270691
8. Baroukh N. N., van Obberghen E., Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS Journal 2009 276 22 6509 6521 10.1111/j.1742-4658.2009.07353.x 2-s2.0-70350433377
9. Yan J.-W., Lin J.-S., He X.-X., The emerging role of miR-375 in cancer. International Journal of Cancer 2014 135 5 1011 1018 10.1002/ijc.28563
10. He X.-X., Chang Y., Meng F.-Y., Wang M.-Y., Xie Q.-H., Tang F., Li P.-Y., Song Y.-H., Lin J.-S., MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012 31 28 3357 3369 10.1038/onc.2011.500 2-s2.0-84863804699
11. Ding L., Xu Y., Zhang W., Deng Y., Si M., Du Y., Yao H., Liu X., Ke Y., Si J., Zhou T., MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Research 2010 20 7 784 793 10.1038/cr.2010.79 2-s2.0-77955708471
12. Mathe E. A., Nguyen G. H., Bowman E. D., MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clinical Cancer Research 2009 15 19 6192 6200 10.1158/1078-0432.CCR-09-1467
13. Avissar M., Christensen B. C., Kelsey K. T., Marsit C. J., MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clinical Cancer Research 2009 15 8 2850 2855 10.1158/1078-0432.CCR-08-3131 2-s2.0-65249186738
14. Szczyrba J., Nolte E., Wach S., Kremmer E., Stöhr R., Hartmann A., Wieland W., Wullich B., Grässer F. A., Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Molecular Cancer Research 2011 9 6 791 800 10.1158/1541-7786.MCR-10-0573 2-s2.0-79959188574
15. Rocha Simonini P. D. S., Breiling A., Gupta N., Malekpour M., Youns M., Omranipour R., Malekpour F., Volinia S., Croce C. M., Najmabadi H., Diederichs S., Sahin Ö., Mayer D., Lyko F., Hoheisel J. D., Riazalhosseini Y., Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor in breast cancer cells. Cancer Research 2010 70 22 9175 9184 10.1158/0008-5472.CAN-10-1318 2-s2.0-78549249846
16. Yu H., Jiang L., Sun C., Guo L., Lin M., Huang J., Zhu L., Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer. Gene 2014 534 1 60 65 10.1016/j.gene.2013.10.024 2-s2.0-84888035824
17. Wu C., Li M., Hu C., Duan H., Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Molecular Biology Reports 2014 41 3 1257 1266 10.1007/s11033-013-2970-z
18. Li Y., Jiang Q., Xia N., Yang H., Hu C., Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. The Journal of International Medical Research 2012 40 5 1662 1669 10.1177/030006051204000505 2-s2.0-84880142343
19. Chang C., Shi H., Wang C., Wang J., Geng N., Jiang X., Wang X., Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neuroscience Letters 2012 531 2 204 208 10.1016/j.neulet.2012.10.021 2-s2.0-84870402500
20. Madhavan D., Zucknick M., Wallwiener M., Cuk K., Modugno C., Scharpff M., Schott S., Heil J., Turchinovich A., Yang R., Benner A., Riethdorf S., Trumpp A., Sohn C., Pantel K., Schneeweiss A., Burwinkel B., Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clinical Cancer Research 2012 18 21 5972 5982 10.1158/1078-0432.CCR-12-1407 2-s2.0-84868547525
21. Ma M.-Z., Kong X., Weng M.-Z., Cheng K., Gong W., Quan Z.-W., Peng C.-H., Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. Journal of Experimental and Clinical Cancer Research 2013 32 1, article 71 10.1186/1756-9966-32-71 2-s2.0-84884660965
22. Nguyen G. H., Schetter A. J., Chou D. B., Bowman E. D., Zhao R., Hawkes J. E., Mathé E. A., Kumamoto K., Zhao Y., Budhu A., Hagiwara N., Wang X. W., Miyashita M., Casson A. G., Harris C. C., Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clinical Cancer Research 2010 16 23 5824 5834 10.1158/1078-0432.CCR-10-1110 2-s2.0-78650398274
23. Kong K. L., Kwong D. L. W., Chan T. H.-M., Law S. Y.-K., Chen L., Li Y., Qin Y.-R., Guan X.-Y., MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012 61 1 33 42 10.1136/gutjnl-2011-300178 2-s2.0-83555177355
24. Li J., Li X., Li Y., Yang H., Wang L., Qin Y., Liu H., Fu L., Guan X.-Y., Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization. PLoS ONE 2013 8 1 e53582 10.1371/journal.pone.0053582 2-s2.0-84871855413
25. Komatsu S., Ichikawa D., Takeshita H., Konishi H., Nagata H., Hirajima S., Kawaguchi T., Arita T., Shiozaki A., Fujiwara H., Okamoto K., Otsuji E., Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opinion on Biological Therapy 2012 12 1 S53 S59 10.1517/14712598.2012.681373 2-s2.0-84861437376
26. Zhang X., Yan Z., Zhang J., Gong L., Li W., Cui J., Liu Y., Gao Z., Li J., Shen L., Lu Y., Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Annals of Oncology 2011 22 10 2257 2266 10.1093/annonc/mdq758 2-s2.0-79959251756
27. Harris T., Jimenez L., Kawachi N., Fan J.-B., Chen J., Belbin T., Ramnauth A., Loudig O., Keller C. E., Smith R., Prystowsky M. B., Schlecht N. F., Segall J. E., Childs G., Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. American Journal of Pathology 2012 180 3 917 928 10.1016/j.ajpath.2011.12.004 2-s2.0-84863141727
28. Jonsdottir K., Janssen S. R., Da Rosa F. C., Gudlaugsson E., Skaland I., Baak J. P. A., Janssen E. A. M., Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers. PLoS ONE 2012 7 11 e48692 10.1371/journal.pone.0048692 2-s2.0-84868685159
29. Carlsen A. L., Joergensen M. T., Knudsen S., De Muckadell O. B. S., Heegaard N. H. H., Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. Pancreas 2013 42 7 1107 1113 10.1097/MPA.0b013e318296bb34 2-s2.0-84885093528
30. Bryant R. J., Pawlowski T., Catto J. W. F., Marsden G., Vessella R. L., Rhees B., Kuslich C., Visakorpi T., Hamdy F. C., Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer 2012 106 4 768 774 10.1038/bjc.2011.595 2-s2.0-84856812332
31. Stroup D. F., Berlin J. A., Morton S. C., Olkin I., Williamson G. D., Rennie D., Moher D., Becker B. J., Sipe T. A., Thacker S. B., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Journal of the American Medical Association 2000 283 15 2008 2012 10.1001/jama.283.15.2008 2-s2.0-0034685429
32. Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010 25 9 603 605 10.1007/s10654-010-9491-z 2-s2.0-77957661914
33. Tierney J. F., Stewart L. A., Ghersi D., Burdett S., Sydes M. R., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007 8, article 16 10.1186/1745-6215-8-16 2-s2.0-34547450763
34. Higgins J. P. T., Thompson S. G., Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002 21 11 1539 1558 10.1002/sim.1186 2-s2.0-0037098199
35. Higgins J. P. T., Thompson S. G., Deeks J. J., Altman D. G., Measuring inconsistency in meta-analyses. British Medical Journal 2003 327 7414 557 560 10.1136/bmj.327.7414.557 2-s2.0-0041876133
36. Duval S., Tweedie R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000 56 2 455 463 10.1111/j.0006-341X.2000.00455.x 2-s2.0-0033934949
37. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., Kawakami K., Chiyomaru T., Yoshino H., Enokida H., Nakagawa M., Okamoto Y., Seki N., Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011 56 8 595 601 10.1038/jhg.2011.66 2-s2.0-80052120906
38. Hui A. B. Y., Bruce J. P., Alajez N. M., Shi W., Yue S., Perez-Ordonez B., Xu W., O'Sullivan B., Waldron J., Cummings B., Gullane P., Siu L., Liu F.-F., Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clinical Cancer Research 2011 17 24 7539 7550 10.1158/1078-0432.CCR-11-2102 2-s2.0-84055212101
39. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L. T., Uchida T., Hijiya N., Matsuura K., Fujioka T., Seto M., Moriyama M., MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3 ζ Cancer Research 2010 70 6 2339 2349 10.1158/0008-5472.CAN-09-2777 2-s2.0-77950250954
40. Li X., Lin R., Li J., Epigenetic silencing of MicroRNA-375 regulates PDK1 expression in esophageal cancer. Digestive Diseases and Sciences 2011 56 10 2849 2856 10.1007/s10620-011-1711-1 2-s2.0-80054774985
41. Wach S., Nolte E., Szczyrba J., Stöhr R., Hartmann A., Ørntoft T., Dyrskjøt L., Eltze E., Wieland W., Keck B., Ekici A. B., Grässer F., Wullich B., MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. International Journal of Cancer 2012 130 3 611 621 10.1002/ijc.26064 2-s2.0-82255163063
42. Selth L. A., Townley S., Gillis J. L., Ochnik A. M., Murti K., Macfarlane R. J., Chi K. N., Marshall V. R., Tilley W. D., Butler L. M., Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. International Journal of Cancer 2012 131 3 652 661 10.1002/ijc.26405 2-s2.0-84861538794
43. Giricz O., Reynolds P. A., Ramnauth A., Liu C., Wang T., Stead L., Childs G., Rohan T., Shapiro N., Fineberg S., Kenny P. A., Loudig O., Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. Journal of Pathology 2012 226 1 108 119 10.1002/path.2978 2-s2.0-80655143934
44. Ward A., Balwierz A., Zhang J. D., Küblbeck M., Pawitan Y., Hielscher T., Wiemann S., Sahin Ö., Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 2013 32 9 1173 1182 10.1038/onc.2012.128 2-s2.0-84874735111
45. Kinoshita T., Nohata N., Yoshino H., Hanazawa T., Kikawa N., Fujimura L., Chiyomaru T., Kawakami K., Enokida H., Nakagawa M., Okamoto Y., Seki N., Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. International Journal of Oncology 2012 40 1 185 193 10.3892/ijo.2011.1196 2-s2.0-84455163058
46. Luo J., Wu J., Li Z., miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma. BioMed Research International 2014 2014 11 374598 10.1155/2014/374598
47. Xu Y., Jin J., Liu Y., Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. PLoS ONE 2014 9 7 e99516
48. Shen Z.-Y., Zhang Z.-Z., Liu H., Zhao E.-H., Cao H., miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Experimental and Therapeutic Medicine 2014 7 6 1757 1761 10.3892/etm.2014.1627 2-s2.0-84898408761
49. Miao L., Liu K., Xie M., Xing Y., Xi T., miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunology, Immunotherapy 2014 63 7 699 711 10.1007/s00262-014-1550-y 2-s2.0-84897367429
50. Chang Y., Yan W., He X., Zhang L., Li C., Huang H., Nace G., Geller D. A., Lin J., Tsung A., MiR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012 143 1 177 187 10.1053/j.gastro.2012.04.009 2-s2.0-84862750365
51. Liu A. M., Poon R. T. P., Luk J. M., MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochemical and Biophysical Research Communications 2010 394 3 623 627 10.1016/j.bbrc.2010.03.036 2-s2.0-77950626836
52. Furuta M., Kozaki K.-I., Tanaka S., Arii S., Imoto I., Inazawa J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2009 31 5 766 776 10.1093/carcin/bgp250 2-s2.0-77952299722
53. Nishikawa E., Osada H., Okazaki Y., Arima C., Tomida S., Tatematsu Y., Taguchi A., Shimada Y., Yanagisawa K., Yatabe Y., Toyokuni S., Sekido Y., Takahashi T., MiR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Research 2011 71 19 6165 6173 10.1158/0008-5472.CAN-11-1020 2-s2.0-80053347466
54. Yoda S., Soejima K., Hamamoto J., Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer. Lung Cancer 2014 85 3 366 372
55. Zhou J., Song S., He S., Zhu X., Zhang Y. I., Yi B., Zhang B., Qin G., Li D., MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway. International Journal of Molecular Medicine 2014 33 4 950 956 10.3892/ijmm.2014.1638 2-s2.0-84899510151
56. Eun J. L., Gusev Y., Jiang J., Nuovo G. J., Lerner M. R., Frankel W. L., Morgan D. L., Postier R. G., Brackett D. J., Schmittgen T. D., Expression profiling identifies microRNA signature in pancreatic cancer. International Journal of Cancer 2007 120 5 1046 1054 10.1002/ijc.22394 2-s2.0-33846813656
57. Wang Y., Tang Q., Li M., Jiang S., Wang X., MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. Biochemical and Biophysical Research Communications 2014 444 2 199 204 10.1016/j.bbrc.2014.01.028 2-s2.0-84894586542
58. Faltejskova P., Svoboda M., Srutova K., Mlcochova J., Besse A., Nekvindova J., Radova L., Fabian P., Slaba K., Kiss I., Vyzula R., Slaby O., Identification and functional screening of microRNAs highly deregulated in colorectal cancer. Journal of Cellular and Molecular Medicine 2012 16 11 2655 2666 10.1111/j.1582-4934.2012.01579.x 2-s2.0-84868144684
59. Wang F., Li Y., Zhou J., Xu J., Peng C., Ye F., Shen Y., Lu W., Wan X., Xie X., MiR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. The American Journal of Pathology 2011 179 5 2580 2588 10.1016/j.ajpath.2011.07.037 2-s2.0-80054991467
60. Wilting S. M., Verlaat W., Jaspers A., Makazaji N. A., Agami R., Meijer C. J. L. M., Snijders P. J. F., Steenbergen R. D. M., Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis. Epigenetics 2013 8 2 220 228 10.4161/epi.23605 2-s2.0-84874360475
61. Ye X.-M., Zhu H.-Y., Bai W.-D., Wang T., Wang L., Chen Y., Yang A.-G., Jia L.-T., Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R. BMC Cancer 2014 14 1, article 134 10.1186/1471-2407-14-134 2-s2.0-84898601995